Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 33.00
-0.40 (-1.20%)
Aug 19, 2026, 12:22 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.31 billion as of August 18, 2026. Its market cap has decreased by -24.97% in one year.
Market Cap
4.31B
Enterprise Value
3.72B
Revenue
53.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.00
ChartMarket Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 4.31B, a decrease of -11.19%. That is a compound annual growth rate of -2.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 4.31B | -35.60% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 5.53B |
| Steminent Biotherapeutics | 5.32B |
| AnnJi Pharmaceutical | 5.17B |
| Mycenax Biotech | 5.06B |
| Medigen Biotechnology | 4.76B |
| Sinew Pharma | 4.51B |
| UnicoCell Biomed | 4.38B |
| Formosa Pharmaceuticals | 3.46B |